Hodges Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$224K	–	242
2021 Q3	$224K	Hold	2,000	–	–	0.02%	228
2021 Q2	$324K	Buy	+2,000	New	+$324K	0.04%	201
2020 Q1	–	Sell	-50,000	Closed	-$3.05M	–	192
2019 Q4	$3.05M	Buy	+50,000	New	+$3.05M	0.4%	80